CH646157A5 - Isoxazole derivatives and pharmaceutical preparations containing them - Google Patents

Isoxazole derivatives and pharmaceutical preparations containing them Download PDF

Info

Publication number
CH646157A5
CH646157A5 CH182981A CH182981A CH646157A5 CH 646157 A5 CH646157 A5 CH 646157A5 CH 182981 A CH182981 A CH 182981A CH 182981 A CH182981 A CH 182981A CH 646157 A5 CH646157 A5 CH 646157A5
Authority
CH
Switzerland
Prior art keywords
methyl
general formula
group
alkyl
isoxazole
Prior art date
Application number
CH182981A
Other languages
German (de)
English (en)
Inventor
Reszo Dr Bognar
Istvan Dr Pelyvas
Ferenc Dr Sztaricskei
Zoltan Dr Gyoergydeak
Jozsef Dr Szegi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of CH646157A5 publication Critical patent/CH646157A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH182981A 1980-03-19 1981-03-18 Isoxazole derivatives and pharmaceutical preparations containing them CH646157A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU8080637A HU180567B (en) 1980-03-19 1980-03-19 Method for producing derivatives of isooxazole

Publications (1)

Publication Number Publication Date
CH646157A5 true CH646157A5 (en) 1984-11-15

Family

ID=10950573

Family Applications (1)

Application Number Title Priority Date Filing Date
CH182981A CH646157A5 (en) 1980-03-19 1981-03-18 Isoxazole derivatives and pharmaceutical preparations containing them

Country Status (15)

Country Link
JP (1) JPS56158774A (it)
BE (1) BE887954A (it)
CA (1) CA1163631A (it)
CH (1) CH646157A5 (it)
DE (1) DE3110817A1 (it)
DK (3) DK151012C (it)
ES (3) ES501095A0 (it)
FI (1) FI70011C (it)
FR (1) FR2478634A1 (it)
GB (1) GB2075009B (it)
HU (1) HU180567B (it)
IT (1) IT1211010B (it)
SE (1) SE454695B (it)
SU (3) SU1053750A3 (it)
YU (1) YU42560B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU733091B2 (en) * 1997-04-21 2001-05-03 Dainippon Sumitomo Pharma Co., Ltd. Isoxazole derivatives
US6100260A (en) * 1997-04-21 2000-08-08 Sumitomo Pharmaceutical Company, Limited Isoxazole derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL302496A (it) * 1962-12-22
US3808221A (en) * 1971-04-14 1974-04-30 Hoffmann La Roche Antiandrogenic n-(3,5-dilower alkyl-4-heterocyclic)methyl)phthalimides

Also Published As

Publication number Publication date
IT1211010B (it) 1989-09-29
DK23087A (da) 1987-01-16
DE3110817A1 (de) 1982-03-04
SE8101703L (sv) 1981-09-20
ES511894A0 (es) 1984-01-01
SU1152518A3 (ru) 1985-04-23
YU68981A (en) 1983-10-31
FI810838L (fi) 1981-09-20
FI70011B (fi) 1986-01-31
DK122581A (da) 1981-09-20
DK153549C (da) 1988-12-05
IT8120395A0 (it) 1981-03-18
ES511895A0 (es) 1983-05-01
SE454695B (sv) 1988-05-24
ES8401758A1 (es) 1984-01-01
ES8305340A1 (es) 1983-05-01
FI70011C (fi) 1986-09-12
DK23187A (da) 1987-01-16
FR2478634B1 (it) 1983-11-10
DK151959C (da) 1988-07-11
FR2478634A1 (fr) 1981-09-25
DK153549B (da) 1988-07-25
HU180567B (en) 1983-03-28
ES8302674A1 (es) 1983-02-16
DK151012B (da) 1987-10-12
GB2075009A (en) 1981-11-11
SU1053750A3 (ru) 1983-11-07
BE887954A (fr) 1981-09-16
DK151959B (da) 1988-01-18
SU1158044A3 (ru) 1985-05-23
GB2075009B (en) 1983-11-30
YU42560B (en) 1988-10-31
ES501095A0 (es) 1983-02-16
DK151012C (da) 1988-07-04
CA1163631A (en) 1984-03-13
JPS56158774A (en) 1981-12-07

Similar Documents

Publication Publication Date Title
DE2604119A1 (de) Neue organische verbindungen und verfahren zu deren herstellung
AT262274B (de) Verfahren zur Herstellung neuer Indolderivate
CH640224A5 (de) 2-pyrrolidonderivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von 4-aminohex-5-ensaeure.
AT200578B (de) Verfahren zur Herstellung von neuen N-Aminoalkylderivaten von Azepinen
DE2347015C2 (de) Neue Pyrazolyloxyessigsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
DE1593728C3 (de) Substituierte Amidine und Verfahren zu ihrer Herstellung
DE3877124T2 (de) Imidazol-derivate, verfahren zu deren herstellung und deren anwendung als alpha-2-adrenoceptor-antagonisten.
DE2118315C3 (de) 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH646157A5 (en) Isoxazole derivatives and pharmaceutical preparations containing them
CH638525A5 (de) 3-(tetrazol-5-yl)-1-azaxanthone und verfahren zu ihrer herstellung.
DE1670032A1 (de) Neue 11-(Piperazinyl)-dibenz (b,f)(1,4)oxazepine und analoge -thiazepine
CH498854A (de) Verfahren zur Herstellung von neuen Furazanderivaten
AT321302B (de) Verfahren zur Herstellung von neuen Aminophenylketonderivaten und ihren Säureadditionssalzen
CH621550A5 (it)
AT269864B (de) Verfahren zur Herstellung von neuen Pyrrylaminoketonderivaten und ihren Salzen
AT256846B (de) Verfahren zur Herstellung von neuen in 5-Stellung substituierten 5,6-Dihydro-6-oxo-pyrido[2,3-b][1,4]benzoxazepinen
AT339482B (de) Verfahren zur herstellung neuer organischer amid-verbindungen
CH535235A (de) Verfahren zur Herstellung neuer reaktionsträger Lysergsäurederivate
DE2338409A1 (de) Neues verfahren zur herstellung von 2-acylamino-benzylaminen
CH535236A (de) Verfahren zur Herstellung neuer reaktionsträger Lysergsäurederivate
AT205031B (de) Verfahren zur Herstellung von neuen, basisch substituierten Derivaten von 4-Aza-phenthiazinen bzw. ihren Salzen
AT270630B (de) Verfahren zur Herstellung von neuen Pyrrolinderivaten und ihren Salzen
AT234691B (de) Verfahren zur Herstellung von neuen Piperidinderivaten
AT355581B (de) Verfahren zur herstellung neuer pyrido- benzodiazepinone und ihrer salze
AT258298B (de) Verfahren zur Herstellung von neuen Derivaten des 5,6-Dihydromorphantridins

Legal Events

Date Code Title Description
PL Patent ceased